{"id":7879,"date":"2025-07-14T14:40:12","date_gmt":"2025-07-14T11:40:12","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=7879"},"modified":"2025-07-14T14:40:12","modified_gmt":"2025-07-14T11:40:12","slug":"acc-backs-ama-resolution-to-boost-lung-cancer-and-heart-disease-screenings-in-smokers-with-low-dose-ct","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/acc-backs-ama-resolution-to-boost-lung-cancer-and-heart-disease-screenings-in-smokers-with-low-dose-ct\/","title":{"rendered":"\u00a0ACC Backs AMA Resolution to Boost Lung Cancer and Heart Disease Screenings in Smokers with Low-Dose CT"},"content":{"rendered":"<div>\u00a0ACC Backs AMA Resolution to Boost Lung Cancer and Heart Disease Screenings in Smokers with Low-Dose CT<\/div>\n<div>Published: June 9, 2025<\/div>\n<div>Source:\u00a0 \u00a0 Final Report of Reference Committee D, containing Resolution 404 \u2013 Improving Public Awareness of Lung Cancer Screening and CAD in Chronic Smokers, issued by the American Medical Association (AMA), 9 June 2025.<\/div>\n<div><\/div>\n<div>Key Points:<\/div>\n<div><span> 1. Dual Screening Initiative:<\/span><\/div>\n<div><span> \u2022 The American College of Cardiology (ACC) is supporting AMA Resolution 404, which promotes the use of low-dose CT (LDCT) for simultaneous screening of lung cancer and coronary artery disease (CAD) in chronic smokers.<\/span><\/div>\n<div><span> \u2022 LDCT can detect lung nodules and assess coronary artery calcium (CAC) as a marker for heart disease risk.<\/span><\/div>\n<div><span> 2. Collaborating Societies:<\/span><\/div>\n<div><span> \u2022 The resolution i\u2026<\/span><\/div>\n<div>[1:58 am, 14\/07\/2025] Dr Jamal Aldabbas Card Socity: Inflammation Playing a Much Bigger Role in Heart Disease Evaluations<\/div>\n<div><\/div>\n<div>Highlighted in June 2025, from a Medscape article originally published in May 2025.<\/div>\n<div><\/div>\n<div>Key Points:<\/div>\n<div><span> 1. Inflammation Takes Center Stage:<\/span><\/div>\n<div><span> \u2022 Inflammation is emerging as a central factor in cardiovascular risk, alongside or even above cholesterol.<\/span><\/div>\n<div><span> \u2022 Dr. Paul Ridker of Harvard emphasizes that high-sensitivity C-reactive protein (hs-CRP) is a key biomarker that can guide both prediction and treatment of heart disease.<\/span><\/div>\n<div><span> 2. CRP Outperforms Traditional Risk Markers:<\/span><\/div>\n<div><span> \u2022 Long-term data from the Women\u2019s Health Study (30,000 women over 30 years) show that hs-CRP is a stronger predictor of cardiovascular events than LDL or Lipoprotein(a).<\/span><\/div>\n<div><span> \u2022 Ignoring inflammation in risk assessment may result in missed opportunities for early prevention.<\/span><\/div>\n<div><span> 3. Screen What You Want to Treat:<\/span><\/div>\n<div><span> \u2022 Ridker calls for routine testing of hs-CRP, LDL, and Lp(a) in both primary and secondary prevention.<\/span><\/div>\n<div><span> \u2022 \u201cDoctors don\u2019t treat what they don\u2019t measure\u201d\u2014inflammation should be screened and addressed like blood pressure or cholesterol.<\/span><\/div>\n<div><span> 4. Pharmaceutical Innovation:<\/span><\/div>\n<div><span> \u2022 In 2023, colchicine became the first FDA-approved drug specifically targeting coronary inflammation.<\/span><\/div>\n<div><span> \u2022 Other drugs, including GLP-1 receptor agonists and SGLT2 inhibitors, also show CRP-lowering effects.<\/span><\/div>\n<div><span> \u2022 Ongoing research is exploring targeted therapies along the IL-1 \u2192 IL-6 \u2192 NLRP3 pathway, relevant to atherosclerosis, HFpEF, and more.<\/span><\/div>\n<div><span> 5. Direct Imaging of Inflammation:<\/span><\/div>\n<div><span> \u2022 New techniques like fat attenuation index (FAI) using cardiac CT allow direct visualization of perivascular inflammation.<\/span><\/div>\n<div><span> \u2022 These tools complement blood biomarkers like CRP, which reflect systemic rather than localized inflammation.<\/span><\/div>\n<div><span> 6. A Simpler, Smarter Approach to Prevention:<\/span><\/div>\n<div><span> \u2022 Ridker warns against over-reliance on costly imaging.<\/span><\/div>\n<div><span> \u2022 He advocates for a simple, cost-effective model using history, physical exam, and three blood tests: LDL, CRP, Lp(a).<\/span><\/div>\n<div><span> \u2022 These tests can guide family screening and catch silent risk early in both prevention settings.<\/span><\/div>\n<div><\/div>\n<div><a href=\"https:\/\/www.medscape.com\/viewarticle\/role-inflammation-heart-disease-what-pcps-should-know-2025a1000c32\">https:\/\/www.medscape.com\/viewarticle\/role-inflammation-heart-disease-what-pcps-should-know-2025a1000c32<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u00a0ACC Backs AMA Resolution to Boost Lung Cancer and Heart Disease Screenings in Smokers with Low-Dose CT Published: June 9, 2025 Source:\u00a0 \u00a0 Final Report of Reference Committee D, containing Resolution 404 \u2013 Improving Public Awareness of Lung Cancer Screening and CAD in Chronic Smokers, issued by the American Medical Association (AMA), 9 June 2025. [&hellip;]<\/p>\n","protected":false},"author":145,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-7879","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/7879","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/145"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=7879"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/7879\/revisions"}],"predecessor-version":[{"id":7886,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/7879\/revisions\/7886"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=7879"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=7879"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=7879"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}